GHRP-6
GHRP-6 (Growth Hormone Releasing Hexapeptide) is a brutal, potent, first-generation secretagogue revered in bodybuilding for its aggressive bulking characteristics. Functioning as an intense synthetic ghrelin mimetic, GHRP-6 triggers severe gastric motility and immense, often uncontrollable appetite stimulation within minutes of administration. While it delivers profound acute surges in Growth Hormone, its crude profile makes it less favorable for clean longevity clinics, but highly strategic for resolving chronic cachexia or driving massive systemic hypertrophy.
Quick Stats
Scientific Data
Mechanism of Action
GHRP-6 is a first-generation hexapeptide growth hormone releasing peptide that activates the ghrelin receptor (GHS-R1a) on pituitary somatotroph cells. It produces a strong, dose-dependent GH release pulse. Unlike Ipamorelin, GHRP-6 is non-selective — it also significantly stimulates appetite via the ghrelin pathway, elevates cortisol, and increases prolactin.
The appetite-stimulating effect is pronounced and is considered either a benefit or drawback depending on the user's goals. For individuals seeking to increase caloric intake (e.g., recovery from illness or muscle building), this is advantageous.
Source: PMID: 9003422
Background & History
GHRP-6 (Growth Hormone Releasing Hexapeptide-6) was the first synthetic GHRP discovered, developed by Cyril Bowers at Tulane University in 1984. It was the compound that revealed the existence of a distinct ghrelin receptor (GHS-R1a) separate from the GHRH receptor — a foundational discovery in endocrinology. The strong appetite stimulation it produces (via central ghrelin mimicry) was initially considered a side effect but has since been recognized as a feature for cachexia and underweight conditions.
Research Use Cases
- ✓Bulking protocols where appetite stimulation is desired
- ✓Cachexia management: cancer, HIV, or chronic illness-related muscle wasting
- ✓GH stimulation in combination with GHRH analogs
- ✓Gastroprotective effects noted in some animal models (similar to BPC-157)
Dosing Protocol
| Typical Dose | 100-300 mcg/injection |
| Frequency | 2-3× daily |
| Half-Life | 15-60 minutes |
| Common Vial Sizes | 5 mg |
Dosing Protocols
Standard Protocol
Body-Weight Dosing Reference
Estimated doses extrapolated from the published research range of 100–300 mcg/day (referenced to 70 kg / 154 lb). These are approximations — consult a qualified healthcare provider for personalised guidance.
| Weight | Low Dose | Target Dose | High Dose |
|---|---|---|---|
| 120 lb(54 kg) | 77 mcg | 154 mcg | 231 mcg |
| 140 lb(63 kg) | 90 mcg | 180 mcg | 270 mcg |
| 160 lb(73 kg) | 104 mcg | 209 mcg | 313 mcg |
| 180 lb(82 kg) | 117 mcg | 234 mcg | 351 mcg |
| 200 lb(91 kg) | 130 mcg | 260 mcg | 390 mcg |
| 220 lb(100 kg) | 143 mcg | 286 mcg | 429 mcg |
| 250 lb(113 kg) | 161 mcg | 323 mcg | 484 mcg |
💉 For exact syringe units based on your vial concentration, use the GHRP-6 Reconstitution Calculator →
Administration
Expected Timeline
Who Is It For?
Muscle Building / Caloric Surplus
HighAppetite stimulation is a feature, not a bug, for hardgainers and mass-building phases.
GH Optimization
ModerateStrong GH pulse — less selective than Ipamorelin but potent raw output.
Reconstitution Example
Safety & Considerations
Research peptide. Strongly stimulates appetite — be aware of this if weight management is a goal. May elevate cortisol and prolactin temporarily. Use on an empty stomach.
Regulatory & Legal Status
Competitive athletes subject to anti-doping controls should not use GHRP-6.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Interactions & Contraindications
Diabetes/insulin resistance: appetite stimulation can make caloric control difficult. Elevated cortisol with chronic use may affect adrenal function and immune status. Strong hunger response within 20 minutes of injection — plan food availability.
Synergies & Common Stacks
GHRH+GHRP synergy: powerful GH output for anabolic and recovery goals. More total GH release than with Ipamorelin but with cortisol/appetite side effects.
Emerging research suggests GHRP-6 and BPC-157 share gastroprotective pathways. May complement each other for GI healing protocols.
GHRP-6 vs. Ipamorelin
| Attribute | GHRP-6 | Ipamorelin |
|---|---|---|
| Selectivity | Non-selective (GH + cortisol + hunger) | Selective (GH only) |
| Appetite Effect | Strong — great for hardgainers | Minimal |
| GH Output | Strong GH pulse | Moderate, clean GH pulse |
| Side Effect Profile | Hunger, cortisol, water retention | Minimal — transient water retention |
| Best For | Bulking, aggressive muscle-building | Long-term anti-aging, fat loss protocol |
Verdict: GHRP-6 outperforms Ipamorelin on GH pulse intensity and appetite stimulation — valuable for aggressive muscle-building phases. For a clean, selective, long-term protocol, Ipamorelin is preferable.
Dosing Quick Reference
Frequently Asked Questions
Does GHRP-6 make you hungry?▼
What is the standard GHRP-6 dose?▼
How does GHRP-6 compare to GHRP-2?▼
References
- Bowers CY “"Growth hormone-releasing peptides".” Journal of Pediatric Endocrinology & Metabolism (1993). PMID: 8186715
📚 Related Articles
Looking for a trusted source? See our recommended suppliers →
Independently tested · COA-verified · Save 10% with our exclusive code